17060567

Source:http://linkedlifedata.com/resource/pubmed/id/17060567

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0027796, umls-concept:C0205100, umls-concept:C0245561, umls-concept:C0282440, umls-concept:C1096777
pubmed:issue	8
pubmed:dateCreated	2006-10-24
pubmed:abstractText	Serotonin (5-HT) and norepinephrine (NE) are involved in pain modulation via descending inhibitory pathways in the brain and spinal cord.
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/0401060
pubmed:citationSubset	AIM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Acetaminophen, http://linkedlifedata.com/resource/pubmed/chemical/Adrenergic Uptake Inhibitors, http://linkedlifedata.com/resource/pubmed/chemical/Analgesics, Non-Narcotic, http://linkedlifedata.com/resource/pubmed/chemical/Norepinephrine, http://linkedlifedata.com/resource/pubmed/chemical/Serotonin Uptake Inhibitors, http://linkedlifedata.com/resource/pubmed/chemical/Thiophenes, http://linkedlifedata.com/resource/pubmed/chemical/duloxetine
pubmed:status	MEDLINE
pubmed:month	Oct
pubmed:issn	1526-632X
pubmed:author	pubmed-author:D'SouzaD NDN, pubmed-author:IyengarSS, pubmed-author:PritchettY LYL, pubmed-author:RaskinJJ, pubmed-author:RoseH LHL, pubmed-author:WaningerAA, pubmed-author:WernickeJ FJF
pubmed:issnType	Electronic
pubmed:day	24
pubmed:volume	67
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	1411-20
pubmed:dateRevised	2006-11-15
pubmed:meshHeading	pubmed-meshheading:17060567-Acetaminophen, pubmed-meshheading:17060567-Adrenergic Uptake Inhibitors, pubmed-meshheading:17060567-Aged, pubmed-meshheading:17060567-Analgesics, Non-Narcotic, pubmed-meshheading:17060567-Diabetic Neuropathies, pubmed-meshheading:17060567-Double-Blind Method, pubmed-meshheading:17060567-Drug Administration Schedule, pubmed-meshheading:17060567-Drug Therapy, Combination, pubmed-meshheading:17060567-Female, pubmed-meshheading:17060567-Humans, pubmed-meshheading:17060567-Male, pubmed-meshheading:17060567-Middle Aged, pubmed-meshheading:17060567-Neuralgia, pubmed-meshheading:17060567-Norepinephrine, pubmed-meshheading:17060567-Pain, pubmed-meshheading:17060567-Palliative Care, pubmed-meshheading:17060567-Peripheral Nervous System Diseases, pubmed-meshheading:17060567-Serotonin Uptake Inhibitors, pubmed-meshheading:17060567-Severity of Illness Index, pubmed-meshheading:17060567-Thiophenes, pubmed-meshheading:17060567-Treatment Outcome
pubmed:year	2006
pubmed:articleTitle	A randomized controlled trial of duloxetine in diabetic peripheral neuropathic pain.
pubmed:affiliation	Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN 46285, USA. jfwernicke@lilly.com
pubmed:publicationType	Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't